222 related articles for article (PubMed ID: 34303375)
21. SLC20A1 is a prospective prognostic and therapy response predictive biomarker in head and neck squamous cell carcinoma.
Qian X; Jin M; Bei Y; Zhou C; Fang S; Liu K
Aging (Albany NY); 2024 Feb; 16(5):4423-4444. PubMed ID: 38412319
[TBL] [Abstract][Full Text] [Related]
22. CCDC71L as a novel prognostic marker and immunotherapy target via lipid metabolism in head and neck squamous cell carcinoma.
Zhang Y; Tang H; Zi M; Zhang Z; Gao Q; Tian S
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(6):101799. PubMed ID: 38367702
[TBL] [Abstract][Full Text] [Related]
23. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
[TBL] [Abstract][Full Text] [Related]
24. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
[TBL] [Abstract][Full Text] [Related]
25. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
[TBL] [Abstract][Full Text] [Related]
26. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancer.
Tu W; Zhu X; Han Y; Wen Y; Qiu G; Zhou C
Oncol Lett; 2015 Nov; 10(5):2967-2973. PubMed ID: 26722273
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and prognostic value of
Qiu S; Li D; Shen Z; Li Q; Shen Y; Deng H; Wu Y; Zhou C
J Cancer; 2021; 12(3):693-702. PubMed ID: 33403027
[No Abstract] [Full Text] [Related]
29. Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression.
Arnold L; Gomez JP; Barry M; Yap M; Jackson L; Ly T; Standing D; Padhye SB; Biersack B; Anant S; Thomas SM
Explor Target Antitumor Ther; 2023; 4(5):1104-1121. PubMed ID: 38023989
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
31. Deregulated HOXB7 Expression Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma and Regulates Cancer Cell Proliferation In Vitro and In Vivo.
Li H; Shen LY; Yan WP; Dong B; Kang XZ; Dai L; Yang YB; Fu H; Yang HL; Zhou HT; Huang C; Liang Z; Xiong HC; Chen KN
PLoS One; 2015; 10(6):e0130551. PubMed ID: 26076456
[TBL] [Abstract][Full Text] [Related]
32. UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
Chen X; Zhang S; Liu C; Li G; Lu S; Wang Y; Zhang X; Huang D; Qiu Y; Liu Y
Onco Targets Ther; 2020; 13():6191-6202. PubMed ID: 32636643
[TBL] [Abstract][Full Text] [Related]
33. Restoration of TET2 deficiency inhibits tumor growth in head neck squamous cell carcinoma.
Huang R; Wang Y; Ge H; Wang D; Wang Y; Zhang W; Yang J; Cheng J
Ann Transl Med; 2020 Mar; 8(6):329. PubMed ID: 32355773
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
Jin Y; Qin X
DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
[TBL] [Abstract][Full Text] [Related]
35. Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma.
Sheng S; Guo B; Wang Z; Zhang Z; Zhou J; Huo Z
Front Mol Biosci; 2021; 8():753563. PubMed ID: 34746236
[No Abstract] [Full Text] [Related]
36. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
37. Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.
Habu N; Imanishi Y; Kameyama K; Shimoda M; Tokumaru Y; Sakamoto K; Fujii R; Shigetomi S; Otsuka K; Sato Y; Watanabe Y; Ozawa H; Tomita T; Fujii M; Ogawa K
BMC Cancer; 2015 Oct; 15():730. PubMed ID: 26483189
[TBL] [Abstract][Full Text] [Related]
38. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
[TBL] [Abstract][Full Text] [Related]
39. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
[TBL] [Abstract][Full Text] [Related]
40. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
